• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Anesthesia Drugs – Worldwide Markets

$2,500.00 – $5,000.00

Clear
SKU: KLI1399472 Categories: Drug Delivery Market Reports, Pharmaceuticals Market Research Pages: 156
  • Description
  • Table of Contents
  • Latest reports

Description

An understanding of the market for anesthesia could be worthwhile to any pharmaceutical marketer and any equity company investing or consulting in this area. Anesthesia markets are in one sense simple: growth in these drugs are correlated to prevalence and incidence in disease, and the resulting increase in procedure volumes. But as this market continues to grow, increased competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas of the world. New products in development may change the market landscape dramatically.

This Kalorama Information report – Anesthesia Drugs: Worldwide Markets – focuses on three primary segments of anesthesia:

 

  • General Anesthesia (Inhalation, Parenteral and Rectal)
  • Local Anesthesia (Topical, Transdermal, Parenteral)
  • Adjunctive Therapies in Anesthesia

 

 

The report covers both currently marketed and late stage development anesthesia drugs in detail. Revenues for each segment were generated using dollar and unit sales for each product.

The report includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information. Statistical information is presented as a worldwide overview, with special emphasis on the U.S. The market segments provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.

The issues and trends addressed in the anesthesia drug market include:

 

  • Regulation of Anesthesia Drugs
  • Dentistry and Anesthesia
  • Anesthesia and Pediatric Applications
  • Anesthesia and Benefits to Depressed Patients
  • Anesthesia and Sleep
  • Gender Differences in Anesthesia Reaction
  • Trends in Conscious Sedation

 

 

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study

Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2006. Historical data is provided for the years 2004 and 2005, with forecast data provided for 2007 through 2011. Compound annual growth rates (CAGRs) are provided for the 2004-2006, 2006-2011 and 2004-2011 periods for each industry segment covered. Competitive analysis is provided for the year 2006 with a projected competitive analysis for 2011.

The forecasted market analysis for 2007-2011 is based on probability of approval and sales of products in late stage development, product marketing, and demographic trends.

As part of its market coverage, the following companies were profiled in this report:

 

  • Abbott Laboratories
  • Abraxis BioScience, Inc.
  • Anesiva, Inc.
  • Baxter International, Inc
  • B. Braun Melsungen AG
  • Dentsply International, Inc.
  • Endo Pharmaceuticals Holdings, Inc.
  • Hospira, Inc.
  • MGI Pharma, Inc
  • Minrad International, Inc.
  • Organon N.V.
  • Roche
  • SkyePharma plc
  • TEVA

 

Table of Contents

Chapter One: Executive Summary

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors

Chapter Two: Introduction The World Anesthesia

  • Drug Market
    • Introduction and History to Anesthesia Drugs
    • Types of Anesthesia
    • General Anesthesia
    • Local Anesthesia
    • Adjunctive Therapies in Anesthesia
    • Routes of Administration
    • Inhalation
    • Mask Inhalation
    • Laryngeal Mask
    • Endotracheal Administration
    • Controlled Respiration
    • Intravenous
    • Topical Application
    • Transdermal/Transmucosal Application
  • Distribution Channels
  • Demographics and Statistics
  • Worldwide Demographics
  • Procedures by Type
  • Complications in Anesthesia

Chapter Three: General Anesthesia

  • Overview
    • Induction of General Anesthesia
    • Preoxygenation
    • Loss of Consciousness
  • Description of Products
    • Diprivan
    • Ultane/Sevorane
    • Ethrane
    • Forane
    • Pentothal
    • Suprane
    • Ketalar
    • Brevital
  • Generic Drug Impact and Availability
  • Research and Development
    • Aquavan
    • Propofol IDD-D
    • Market Size and Growth
    • Competitive Analysis

Chapter Four: Local Anesthesia

  • Overview
    • Techniques of Administration
    • Topical Application
    • Transdermal/Transmucosal
    • Simple Local Infiltration
    • Regional Injections
    • Spinal and Epidural Anesthesia
    • Intrathecal Block
    • Epidural, Peridural Block
  • Description of Products
    • AminoAmides
    • Xylocaine/LidoSite/Lidoderm/Dentipatch
    • Carbocaine/Isocaine/Polocaine
    • Marcaine/Sensorcaine
    • Citanest
    • Naropin
    • Septocaine
    • Amino Esters
    • Novocaine
    • Cetacaine/Pontocaine
    • Nesacaine
    • Cocaine Hydrochloride
    • Strocain /Mucaine
    • Combinations
    • Synera/Pliaglis
    • EMLA
    • Duocaine
    • Exactacain
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
  • Competitive Analysis

Chapter Five: Adjunctive Therapies in Anesthesia

  • Overview
    • Description of Products
    • Neuromuscular Blocking Agents
    • Preanesthetic Sedation and Anesthesia Maintenance
    • Anesthesia Reversal Agents
    • Generic Drug Impact and Availability
    • Research and Development
    • Market Size and Growth
    • Competitive Analysis

Chapter Six: Anesthesia Drugs: Total Market Size and Forecast

  • Total Market Size and Forecast
    • Competitor Analysis

Chapter Seven: Issues and Trends

  • Anesthesia Drug Market
  • Introduction
  • Regulation of Anesthesia Drugs
  • Dentistry and Anesthesia
  • Anesthesia and Complications in Pediatric Applications
  • Anesthesia and the Benefits to Depression Patients
  • Anesthesia and Sleep
  • Gender Differences in Anesthesia Reaction
  • Trends in Conscious Sedation

Chapter Eight: Corporate Profiles

  • Introduction
    • Abbott Laboratories
    • Abraxis BioScience, Inc
    • Anesiva, Inc.
    • Baxter International, Inc.
    • B. Braun Melsungen AG
    • Dentsply International, Inc.
    • Endo Pharmaceuticals Holdings, Inc
    • Hospira, Inc.
    • MGI Pharma, Inc.
    • Minrad International, Inc.
    • Organon N.V.
    • Roche.
    • SkyePharma plc
    • TEVA

Appendix: Anesthesia List of Companies

table of exhibits

Chapter One: Executive Summary

  • Table 1-1: The Market for Anesthesia Drugs 2004-2011
  • Figure 1-1: The Market for Anesthesia Drugs 2004-2011

Chapter Two: Introduction: The World Anesthesia  Drug Market

  • Table 2-1: World Population by Selected Geographical Region, 2006-2050
  • Figure 2-1: World Population by Selected Geographical Region, 2006-2050
  • Table 2-2: Estimated World Population by Age and Geographical Region, 2006
  • Table 2-2: Estimated World Population by Age and Geographical Region, 2006
  • Table 2-3: Procedures by Type, 2006
  • Figure 2-3: Procedures by Type Worldwide, 2006
  • Figure 2-4: Procedures by Type U.S., 2006
  • Table 2-4: Worldwide Anesthesia Complications and Related Mortality
  • Figure 2-5: Worldwide Anesthesia Complications and Related Mortality

Chapter Three: General Anesthesia

  • Table 3-1: Marketed Brands for General Anesthesia Drugs  (Type, Brand, and Manufacturer)
  • Table 3-2: Selected Generic Drug Manufacturers and Products for General Anesthesia
  • Figure 3-1: Brand vs. Generic General Anesthetic Market 2004-2006
  • Table 3-3: General Anesthesia Drugs in Development
  • Table 3-4: The Market for General Anesthesia Drugs 2004-2011
  • Figure 3-2: The Market for General Anesthesia Drugs 2004-2011
  • Table 3-5: The Market for General Anesthesia Drugs Estimated Products Sales by Delivery Method, 2006 (Inhalation, Parenteral and Rectal, Total)   
  • Figure 3-3: The Market for General Anesthesia Drugs Market Share by Delivery Method, 2006  (Inhalation, Parenteral and Rectal, Total)
  • Table 3-6: The Market for General Anesthesia Drugs Estimated Products Sales by Geographic Region, 2006 (U.S., E.U., Rest of World)
  • Figure 3-4: The Market for General Anesthesia Drugs Market Share by Geographic Region, 2006 (U.S., E.U., Rest of World)     
  • Table 3-7: The Market for General Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2006
  • Figure 3-5: The Market for General Anesthesia Drugs Estimated Market Share by Leading Suppliers 2006

Chapter Four: Local Anesthesia

  • Table 4-1: Selected Marketed Local Anesthesia Drugs  (Type, Brand, and Manufacturer)
  • Table 4-2: Selected Generic Drug Manufacturers and Products for Local Anesthesia
  • Figure 4-1: Brand vs. Generic Local Anesthetic Market 2004-2006
  • Table 4-3: Local Anesthesia Drugs in Development
  • Table 4-4: The Market for Local Anesthesia Drugs 2004-2011
  • Figure 4-2: The Market for Local Anesthesia Drugs 2004-2011
  • Table 4-5: The Market for Local Anesthesia Drugs Estimated Products Sales by Delivery Method, 2006 (Topical, Transdermal/Transmucosal, Parenteral)
  • Figure 4-3: The Market for Local Anesthesia Drugs Market Share by Delivery Method, 2006 (Topical, Transdermal/Transmucosal, Parenteral)
  • Table 4-6: The Market for Local Anesthesia Drugs Estimated Products Sales by Geographic Region, 2006 (U.S., E.U., Rest of World)
  • Figure 4-4: The Market for Local Anesthesia Drugs Market Share by Geographic Region, 2006 (U.S., E.U., Rest of World)
  • Table 4-7: The Market for Local Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2006
  • Figure 4-5: The Market for Local Anesthesia Drugs Estimated Market Share by Leading Suppliers 2006   

Chapter Five: Adjunctive Therapies in Anesthesia

  • Table 5-1: Selected Marketed Adjunctive Therapies in Anesthesia  (Type, Brand, and Manufacturer)
  • Table 5-2: Selected Generic Drug Manufacturers and Products for Adjunctive Therapies in Anesthesia
  • Figure 5-1: Brand vs. Generic Adjunctive Therapies in Anesthesia Market 2004-2006
  • Table 5-3: Adjunctive Therapies in Anesthesia in Development
  • Table 5-4: The Market for Adjunctive Therapies in Anesthesia 2004-2011
  • Figure 5-2: The Market for Adjunctive Therapies in Anesthesia 2004-2011
  • Table 5-5: The Market for Adjunctive Therapies in Anesthesia Estimated Products Sales by Geographic Region, 2006 (U.S., E.U., Rest of World)
  • Figure 5-3: The Market for Adjunctive Therapies in Anesthesia Market Share by Geographic Region, 2006 (U.S., E.U., Rest of World)
  • Table 5-6: The Market for Adjunctive Therapies in Anesthesia Estimated Revenues and Market Share of Leading Suppliers 2006
  • Figure 5-4: The Market for Adjunctive Therapies in Anesthesia Estimated Market Share by Leading Suppliers 2006

Chapter Six: Anesthesia Drugs: Total Market Size and Forecast

  • Table 6-1: The Market for Anesthesia Drugs 2004-2011
  • Figure 6-1: The Market for Anesthesia Drugs 2004-2011
  • Table 6-2: Anesthesia Drug Market by Type  2004-2011
  • Figure 6-2: Anesthesia Drug Market by Type  2004-2011
  • Figure 6-3: Anesthesia Drug Market by Type  2006 (General, Local, Adjunctive Anesthesia)
  • Figure 6-4: Anesthesia Drug Market by Type  2011
  • Table 6-3: Leading Suppliers Anesthesia Revenues and Significant Segments of Participation, 2006 (General, Local, Adjunctive)

 

    The Market for Needle-Free Drug Delivery Systems
    July 14, 2016
    Transdermal and Transmucosal Drug Delivery Markets: Forecasts to 2020
    November 25, 2015
    The World Market for Implantable and Needle-Free Drug Delivery Systems
    December 11, 2013
    The World Market for Transdermal Drug Delivery
    September 13, 2012

Related products

  • Placeholder image

    Advanced Drug Delivery: Technologies, Applications, and Markets

    $2,625.00 – $5,250.00
  • Placeholder image

    U.S. Market for OTC Diet Aids, The

    $3,000.00 – $6,000.00
  • Placeholder image

    World Market for Anti-infectives Volume III: The World Market for Antiviral Medications, The

    $1,875.00 – $3,750.00
  • Placeholder image

    The Market for Lead Optimization Tools and Services: Applying the New “Omics” to Enhance Drug Discovery

    $1,875.00 – $3,750.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Anti-Infectives: World Markets, 2nd Edition, Vol. I-III (Complete Series)OEM Contract Manufacturing in Medical Devices, Vol I: Materials Processing
Scroll to top